Phase II Single-Arm Study of ON 01910.Na by 2-hr Infusion in Patients With Recurring Platinum-Resistant Ovarian Cancer.
Latest Information Update: 07 May 2024
At a glance
- Drugs Rigosertib (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Traws Pharma
Most Recent Events
- 31 Dec 2011 Actual patient number is 1 as reported by ClinicalTrials.gov.
- 13 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 13 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.